Moderna Targets Big Profits By Supplying Most Of Its COVID19 Vaccine Doses To High Income Countries
A COVID19 vaccine that has been developed by Moderna has been proved to be one of the most effective tools against the SARS-CoV-2 virus. Now…
COVID19
Immunity From Prior COVID19 Infection Produces More Robust Secondary Immune Response As Compared To Vaccines
A new study has shown that prior COVID19 infection generates a more robust secondary immune response as compared to COVID19 shots. The authors of the…